Efficacy and Safety of the Iron Chelator Deferiprone on Iron Overload in the Brain in Parkinson's Disease.
Phase of Trial: Phase II/III
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Deferiprone (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- Acronyms FAIR-PARK-I
- 23 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2011 Planned end date changed from 1 Nov 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 21 Oct 2010 New trial record.